ERBB2 and breast carcinoma: OC demonstrated antiproliferative, apoptotic, anti-angiogenic, antimigratory, anti-invasive, and antimetastatic effects, mainly on breast cancer, by targeting ERα, HER2, EGFR, and c-MET.